• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗一所三级大学附属医院重症监护病房患者分离细菌的抗菌药物敏感性监测:2006-2009 年。

Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.

机构信息

Department of Pathology, Masih Daneshvari Hospital, National Research Institute of Tuberculosis and Lung Diseases, Shaheed Beheshti University of Medical Sciences and Health Services, Shaheed Bahonar Avenue, Darabad, Tehran, Iran.

出版信息

Chemotherapy. 2010;56(6):478-84. doi: 10.1159/000321032. Epub 2010 Nov 23.

DOI:10.1159/000321032
PMID:21099220
Abstract

BACKGROUND

This study was conducted to determine the antimicrobial susceptibility patterns among common pathogens in the intensive care unit (ICU) of a university hospital in Iran between 2006 and 2009.

METHODS

The isolates cultured in appropriate media and antimicrobial susceptibility were determined by disk diffusion tests according to the guidelines of the Clinical and Laboratory Standards Institute.

RESULTS

A total of 606 isolates were recovered from respiratory (70.63%), urine (20.13%), blood (4.95%) and wound (1.82%) specimens of 456 patients. The most common isolates were Acinetobacter baumannii (22.4%), Pseudomonas aeruginosa (20.6%), Staphylococcus aureus (11.1%), Escherichia coli (8.3%) and Klebsiella pneumoniae (4.8%). Less than 7% of A. baumannii isolates were susceptible to aminoglycosides, ceftazidime, cefotaxime, imipenem, cefepime and ciprofloxacin. None was susceptible to piperacillin and piperacillin-tazobactam. The susceptibility rates of P. aeruginosa to ciprofloxacin, gentamicin and piperacillin-tazobactam were 13.6, 17.4 and 33.3%, respectively. Methicillin-resistant S. aureus made up 96.2% of S. aureus isolates and was 100% susceptible to vancomycin and 51.9% susceptible to trimethoprim-sulfamethoxazole.

CONCLUSION

Due to the high antimicrobial resistance in the ICU, we must focus on both a wiser use of antimicrobials and the prevention of infection.

摘要

背景

本研究旨在确定 2006 年至 2009 年期间伊朗一所大学医院重症监护病房(ICU)中常见病原体的药敏模式。

方法

将培养于适当培养基中的分离物进行培养,并根据临床和实验室标准协会的指南通过纸片扩散试验确定其药敏性。

结果

从 456 名患者的呼吸道(70.63%)、尿液(20.13%)、血液(4.95%)和伤口(1.82%)标本中分离出 606 株分离物。最常见的分离物是鲍曼不动杆菌(22.4%)、铜绿假单胞菌(20.6%)、金黄色葡萄球菌(11.1%)、大肠杆菌(8.3%)和肺炎克雷伯菌(4.8%)。少于 7%的鲍曼不动杆菌分离株对氨基糖苷类、头孢他啶、头孢噻肟、亚胺培南、头孢吡肟和环丙沙星敏感。对哌拉西林和哌拉西林-他唑巴坦均无敏感性。铜绿假单胞菌对环丙沙星、庆大霉素和哌拉西林-他唑巴坦的药敏率分别为 13.6%、17.4%和 33.3%。耐甲氧西林金黄色葡萄球菌占金黄色葡萄球菌分离株的 96.2%,对万古霉素 100%敏感,对复方磺胺甲噁唑 51.9%敏感。

结论

由于 ICU 中抗菌药物的高度耐药性,我们必须同时关注更明智地使用抗菌药物和预防感染。

相似文献

1
Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.伊朗一所三级大学附属医院重症监护病房患者分离细菌的抗菌药物敏感性监测:2006-2009 年。
Chemotherapy. 2010;56(6):478-84. doi: 10.1159/000321032. Epub 2010 Nov 23.
2
Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.墨西哥一家三级教学医院的多药耐药菌流行情况:特别关注鲍曼不动杆菌。
Chemotherapy. 2010;56(4):275-9. doi: 10.1159/000319903. Epub 2010 Aug 9.
3
[Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].[对从重症监护病房和住院诊所患者中分离出的铜绿假单胞菌和鲍曼不动杆菌菌株的抗生素敏感性率进行四年监测]
Mikrobiyol Bul. 2008 Apr;42(2):321-9.
4
Comparison of trends of resistance rates over 3 years calculated from results for all isolates and for the first isolate of a given species from a patient.根据所有分离株以及来自某患者的特定菌种的首个分离株的结果计算得出的3年期间耐药率趋势的比较。
J Clin Microbiol. 2004 Oct;42(10):4776-9. doi: 10.1128/JCM.42.10.4776-4779.2004.
5
Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.泛耐药肺炎克雷伯菌、铜绿假单胞菌和鲍曼不动杆菌感染:28例患者的特征及转归
Int J Antimicrob Agents. 2008 Nov;32(5):450-4. doi: 10.1016/j.ijantimicag.2008.05.016. Epub 2008 Sep 2.
6
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
7
Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.爱沙尼亚重症监护病房中鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌的流行情况及抗生素敏感性:与欧洲数据的比较
Scand J Infect Dis. 2006;38(11-12):1001-8. doi: 10.1080/00365540600786507.
8
Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.多黏菌素对鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌临床分离株的突变预防浓度。
J Antimicrob Chemother. 2014 Jan;69(1):275-7. doi: 10.1093/jac/dkt315. Epub 2013 Aug 29.
9
Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.加拿大鲍曼不动杆菌和耐美罗培南铜绿假单胞菌的特征:CANWARD 2007-2009 研究结果。
Diagn Microbiol Infect Dis. 2011 Mar;69(3):335-41. doi: 10.1016/j.diagmicrobio.2010.10.030.
10
Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.2001 - 2003年德国重症监护病房细菌耐药性的时间变化:来自SARI(重症监护病房抗菌药物使用与抗菌药物耐药性监测)项目的数据。
J Hosp Infect. 2005 Aug;60(4):348-52. doi: 10.1016/j.jhin.2004.12.027.

引用本文的文献

1
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.鲍曼不动杆菌对碳青霉烯类耐药的地理分布及时间趋势:一项综合荟萃分析。
PLoS One. 2024 Dec 16;19(12):e0311124. doi: 10.1371/journal.pone.0311124. eCollection 2024.
2
Integration of phenotypic, qPCR and genome sequencing methodologies for the detection of antimicrobial resistance and virulence in clinical isolates of a tertiary hospital, India.印度一家三级医院临床分离株中抗菌药物耐药性和毒力检测的表型、定量聚合酶链反应和基因组测序方法的整合
3 Biotech. 2023 Nov;13(11):368. doi: 10.1007/s13205-023-03797-4. Epub 2023 Oct 15.
3
The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016.
制裁与医疗体系改革对伊朗2001 - 2016年医疗绩效及药品市场的影响
J Pharm Policy Pract. 2020 Aug 27;13:50. doi: 10.1186/s40545-020-00245-z. eCollection 2020.
4
Frequency of 16S rRNA Methylase and Aminoglycoside-Modifying Enzyme Genes among Clinical Isolates of  in Iran.伊朗临床分离株中16S rRNA甲基化酶和氨基糖苷类修饰酶基因的频率
Iran J Pathol. 2017 Fall;12(4):329-338. Epub 2017 Oct 1.
5
Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis.伊朗鲍曼不动杆菌对亚胺培南的耐药性:一项系统评价和荟萃分析。
Open Microbiol J. 2016 Mar 29;10:32-42. doi: 10.2174/1874285801610010032. eCollection 2016.
6
Detection of Metallo-Beta Lactamases Among Carbapenem-Resistant Pseudomonas aeruginosa.耐碳青霉烯类铜绿假单胞菌中金属β-内酰胺酶的检测
Jundishapur J Microbiol. 2014 Nov;7(11):e12289. doi: 10.5812/jjm.12289. Epub 2014 Nov 1.
7
Detection of quinolone-resistance mutations of parC gene in clinical isolates of Acinetobacter baumannii in Iran.伊朗鲍曼不动杆菌临床分离株中parC基因喹诺酮耐药性突变的检测
J Res Med Sci. 2014 Jun;19(6):567-70.
8
Risk factors and prevalence of high resistant Acinetobacter spp among hospitalized patients.住院患者中高耐药不动杆菌属的危险因素及患病率
J Res Med Sci. 2014 May;19(5):480-1.
9
Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran.伊朗鲍曼不动杆菌临床分离株中黏菌素敏感性的检测
J Res Med Sci. 2014 Mar;19(Suppl 1):S67-70.
10
The antibiotic resistance profiles of bacterial strains isolated from patients with hospital-acquired bloodstream and urinary tract infections.从医院获得性血流感染和尿路感染患者中分离出的细菌菌株的抗生素耐药谱。
Crit Care Res Pract. 2012;2012:890797. doi: 10.1155/2012/890797. Epub 2012 Dec 12.